Regulus Therapeutics Inc. Uncategorized Contracts & Agreements
33 Contracts & Agreements
- Preston Klassen, Yearly Discretionary Base Salary Increase, effective January 1, 2024 (Filed With SEC on March 21, 2024)
- Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2024 (Filed With SEC on March 21, 2024)
- Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2024 (Filed With SEC on March 21, 2024)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2024 (Filed With SEC on March 21, 2024)
- Offer Letter Agreement, dated June 12, 2023, by and between the Registrant and Preston Klassen, M.D (Filed With SEC on August 8, 2023)
- Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2023 (Filed With SEC on March 23, 2023)
- Denis Drygin, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Cris Calsada, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Christopher Aker, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2022 (Filed With SEC on March 11, 2022)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2020 (Filed With SEC on March 9, 2021)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2019 (Filed With SEC on March 9, 2021)
- Offer Letter Agreement, dated July 29, 2019, by and between the Company and Cris Calsada (Filed With SEC on July 30, 2019)
- Agreement, dated February 19, 2019, by and between the Registrant and Nitto Biopharma, Inc (Filed With SEC on March 18, 2019)
- Letter Agreement, dated May 8, 2018, by and between the Registrant and AstraZeneca AB (Filed With SEC on August 9, 2018)
- Daniel R. Chevallard, Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Mark Deeg, M.D., Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Timothy Wright, Ph.D., Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Joseph P. Hagan, Yearly Discretionary Base Salary Increase, effective January 1, 2018 (Filed With SEC on May 10, 2018)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- Regulus Therapeutics Inc. Timothy Wright, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- Regulus Therapeutics Inc. Joseph P. Hagan Yearly Discretionary Base Salary Increase (Filed With SEC on May 5, 2017)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on May 3, 2016)
- LICENSING AGREEMENT between ETH Zurich Raemistrasse 101, 8092 Zurich, Switzerland (hereinafter referred to as Licensor or ETH) and Regulus Therapeutics Inc. Rutherford Road,... (Filed With SEC on February 23, 2016)
- EXHIBIT A [***] (Filed With SEC on May 8, 2015)
- Regulus Therapeutics Inc. David L. Szekeres Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. Neil W. Gibson, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- Regulus Therapeutics Inc. Kleanthis G. Xanthopoulos, Ph.D. Yearly Discretionary Base Salary Increase (Filed With SEC on February 19, 2015)
- PRODUCTDEVELOPMENT AND COMMERCIALIZATION AGREEMENT BETWEEN GLAXO GROUP LIMITED AND REGULUS THERAPEUTICS LLC (Filed With SEC on September 18, 2012)
- INDEMNITY AGREEMENT (Filed With SEC on August 17, 2012)
